|会社名||Inogen Inc （イノジェン）|
|分野（sector）||Health Care ヘルスケア|
|業種||医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care）|
|概要||事業概要 イノゲン(Inogen Inc.)は医療技術会社である。同社は慢性呼吸器疾患に罹患している患者に補助的な長期酸素療法を提供するために使用される携帯用酸素濃縮器を開発・製造・販売している。同社のInogen Oneシステムは患者の周りに空気を集中させ、いつでも、どこでもポータブル機器を使用して単一酸素供給源を提供する。Inogen One G4、Inogen One G3、Inogen One G2の3つのポータブル製品は、それぞれ約2.8、4.8、7.0ポンドで、1つのバッテリで動作する。そのInogen One G4、Inogen One G3およびInogen One G2はそれぞれ、サブ3、サブ5およびサブ10ポンドのポータブル酸素濃縮器である。すべてのInogen Oneシステムにはインテリジェント配信技術が搭載されている。Inogen At Homeの固定式酸素濃縮装置は、外来酸素患者市場にアクセスすることを可能にし、レンタルサービスの外来患者に対するInogen Oneシステムのバックアップとして機能する。 イノジェンは米国の医療技術企業。慢性呼吸器系疾患患者への携帯用酸素濃縮器を開発、製造、販売する。独自技術のイノジェン・ワンは、約4.8ポンドまたは7ポンドの重量の携帯用デバイスにより患者の回りの空気を集結させて、酸素補給を可能にする。イノジェン・ワンG2及びG3は、単一バッテリ―で4.5時間から5時間まで使用可能。 Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.|
|本社所在地||326 Bollay Drive Goleta CA 93117 USA|
|代表者氏名||Heath Lukatch ヒース・ルカッチ|
|代表者役職名||Independent Chairman of the Board|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 Inogen Inc revenues increased 51% to $176.3M. Net income increased 78% to $25.4M. Revenues reflect Sales revenue increase of 59% to $165.6M. Net income benefited from Interest Income increase from $247K to $1.2M (income). Basic Earnings per Share excluding Extraordinary Items increased from $0.69 to $1.20.|
Inogen (NASDAQ:INGN) Lowered to Sell at StockNews.com 2023/04/04 06:50:41 The AM Reporter
StockNews.com cut shares of Inogen (NASDAQ:INGN – Get Rating) from a hold rating to a sell rating in a report issued on Monday morning. A number of other equities research analysts have also recently commented on INGN. William Blair cut shares of Inogen from an outperform rating to a market perform rating in a report […]
Sight Sciences ropes in Inogen''s longtime CFO and cofounder Bauerlein for top finance job 2023/04/03 20:41:20 Seeking Alpha
Sight Sciences (SGHT) on Monday named Alison Bauerlein chief financial officer and treasurer, effective April 3, 2023.
Inogen (INGN) Investor Presentation - Slideshow 2023/03/24 16:55:36 Seeking Alpha
The following slide deck was published by Inogen, Inc.
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda 2023/03/22 20:05:00 Wallstreet:Online
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of Directors, effective April 1, 2023. The company also announced that Kristen Miranda, who has served as a director since March 2021, will retire as a member of the Board of Directors, effective March
Inogen: Downside Appears Limited, Upgrade To Hold (NASDAQ:INGN) 2023/03/06 18:46:43 Seeking Alpha
Supply chain issues caused major problems for Inogen in FY22, and continued headwinds are expected in FY23. See why I upgrade INGN stock to a hold.
Inogen Inc. (INGN) Q4 2022 Earnings Call Transcript 2023/02/24 02:33:02 Seeking Alpha
Inogen Inc. (NASDAQ:NASDAQ:INGN) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ETCompany ParticipantsAgnes Lee - SVP of IR and Strategic PlanningNabil Shabshab - President and…
Inogen: Q4 Earnings Snapshot 2023/02/23 21:50:52 WTOP
GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Thursday reported a loss of $56.6 million in…
Inogen Non-GAAP EPS of -$0.57 beats by $0.08, revenue of $88.09M misses by $1.61M 2023/02/23 21:13:44 Seeking Alpha
Inogen press release (INGN): Q4 Non-GAAP EPS of -$0.57 beats by $0.08.Revenue of $88.09M (+15.3% Y/Y) misses by $1.61M.
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results 2023/02/23 21:02:00 Business Wire
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Fourth Quarter and Full Year 2022 Financial Results
INGN stock lower as William Blair downgrades on macro headwinds (NASDAQ:INGN) 2023/01/17 16:42:11 Seeking Alpha
The shares of Inogen Inc. (INGN) fell in the morning hours Tuesday after William Blair downgraded it to Market Perform from Outperform, citing macro headwinds. Read the full story here.
Inogen Inc. (NASDAQ: INGN): A Sinfully Good Stock To Watch 2022/05/07 13:30:00 Stocks Register
Inogen Inc. (NASDAQ:INGN) price on Friday, May 06, rose 3.53% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $24.94. A look at the stock’s price movement, the close in the last trading session was $24.09, moving within a range at $23.04 and $25.09. The beta value (5-Year … Inogen Inc. (NASDAQ: INGN): A Sinfully Good Stock To Watch Read More »
Inogen GAAP EPS of -$0.62 misses by $0.11, revenue of $80.4M beats by $3.84M 2022/05/05 20:21:57 Seeking Alpha
Inogen press release (INGN): Q1 GAAP EPS of -$0.62 misses by $0.11.Revenue of $80.4M (-7.5% Y/Y) beats by $3.84M.
Inogen Announces First Quarter 2022 Financial Results 2022/05/05 20:05:00 Business Wire
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2022. First Quarter 2022 Highlights Total revenue of $80.4 million, down 7.5% from the same period in 2021, primarily due to supply chain constraints Total revenue up 5.2% sequentially from the fourth quarter of 2021 Domestic direct-to-consumer revenue of $34.4 mi
Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022 2022/04/14 10:00:00 Business Wire
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589
Portable Oxygen Concentrators Market Size to Grow by USD 1.51 Bn| Increasing prevalence of respiratory diseases to boost market growth| Technavio 2022/04/08 00:00:00 Benzinga
NEW YORK , April 7, 2022 /PRNewswire/ -- According to the research report, Portable Oxygen Concentrators Market will witness a YOY growth of 8.8% in 2022 at a CAGR of 12.52% during the forecast period. The report is segmented by product (pulse dose and continuous flow) and geography ( North America , Europe , Asia , and Rest of World (ROW)). The rising frequency of respiratory illnesses is one of the major reasons driving the worldwide portable oxygen concentrators market. For more insights on YOY and CAGR, Read our FREE Sample Report Vendor Insights Portable Oxygen Concentrators Market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.